Virus Diseases: all 927 studies
Page 8 of 10. Open to participants first (112), then studies with results posted, then the rest; newest registration first within each.
- A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.CompletedNCT02733068Phase 3
- Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy AdultsCompletedNCT02718469Phase 1
- A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus InfectionCompletedNCT02716428Phase 2
- A Retrospective Chart Review Study of Gene-Eden-VIR/NovirinCompletedNCT02715752
- RT-PCR on Urine Samples: Added Value for the Diagnosis of Chikungunya Virus InfectionWithdrawnNCT02714985
- Efficacy of Favipiravir Against Severe Ebola Virus DiseaseCompletedNCT02662855Phase 2
- Evaluation of the FilmArray BioThreat-E TestCompletedNCT02658331
- Viral Inhibition in Children for Treatment of RSVCompletedNCT02654171Phase 2
- Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o.CompletedNCT02644018Phase 3
- Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima PeruCompletedNCT02630082Not applicable
- Analysis of Human to Human Transmission of Middle East Respiratory Syndrom Coronavirus (MER-CoV)CompletedNCT02605109
- A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) InfectionTerminatedNCT02593851Phase 1
- A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus InfectionCompletedNCT02593162Phase 2
- Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in IndiaCompletedNCT02592057
- A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease VaccineCompletedNCT02575456Phase 2
- Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus InfectionCompletedNCT02562742
- HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3CompletedNCT02558803Not applicable
- Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV VaccineCompletedNCT02546752Early Phase 1
- Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus InfectionCompletedNCT02537379
- A Booster Dose of Ad5-EBOV in Healthy Adults After Primary ImmunizationCompletedNCT02533791Phase 1
- Multivirus-specific Cytotoxic T Lymphocytes (mCTL)CompletedNCT02510404Phase 1
- Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected PatientsActive, not recruitingNCT02500849Phase 1
- A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOVCompletedNCT02495246Phase 1
- Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)TerminatedNCT02478229Phase 3
- Assessment of Community Transmission of Sabin Type 2 Virus in BangladeshStatus unknownNCT02477046Phase 3
- A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus VaccineCompletedNCT02472548Phase 1
- Effectiveness of Trivalent Inactivated Influenza Maternal Vaccination Among Pregnant Women and Their Newborns in South AfricaStatus unknownNCT02465190
- A Study of AK0529 in Infants Hospitalized With RSVTerminatedNCT02460016Phase 1
- Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in ChinaStatus unknownNCT02456610Phase 1
- Review of Human Herpes Viruses in BurnsCompletedNCT02452229
- Replacement of Lamivudine by Telbivudine to Improve Renal FunctionCompletedNCT02447705Phase 2/3
- Ebola Virus Disease Survivors: Clinical and Immunologic Follow-upCompletedNCT02431923
- Analysis of Viral Infections' Exposition Preceding the Type 1 Diabetes (T1D) Diagnostic in Children of the Isis-Diab Cohort. Search for Explanations of of the Disease's Early OnsetStatus unknownNCT02425410
- The Epidemiology of Hepatitis E Virus Infection in Israel and Potential Risk FactorsStatus unknownNCT02419625Not applicable
- A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China.CompletedNCT02401373Phase 1
- Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted PatientsStatus unknownNCT02395198
- Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection.CompletedNCT02387606Phase 2
- Multiple Treatments for Ebola Virus Disease (EVD)Status unknownNCT02380625Phase 1/2
- Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)CompletedNCT02368119Phase 1
- Phase 1 Trial of Inactivated West Nile Virus VaccineCompletedNCT02337868Phase 1
- A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug UseCompletedNCT02336139Phase 2
- Chronic Fatigue Following Acute Epstein-Barr Virus Infection in AdolescentsCompletedNCT02335437
- Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola TreatmentStatus unknownNCT02333578Not applicable
- A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.CompletedNCT02326194Phase 1
- Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)WithdrawnNCT02313844Phase 1
- HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus InfectionCompletedNCT02309918Phase 2
- Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)WithdrawnNCT02307591Phase 2/3
- A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.Status unknownNCT02296983Phase 1
- A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus DiseaseTerminatedNCT02295501Phase 1
- An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm InfantsCompletedNCT02273882
- An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus DiseaseWithdrawnNCT02271347Phase 2
- Phase 1 Trial of Ebola Vaccine in MaliCompletedNCT02267109Phase 1
- Respiratory Viral Infections in Pediatric TransplantationCompletedNCT02260596
- Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus InfectionCompletedNCT02254707Phase 1/2
- Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus InfectionCompletedNCT02253550Phase 2
- Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly PopulationCompletedNCT02236052Phase 2
- Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in AdultsCompletedNCT02233816Phase 2
- Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus InfectionCompletedNCT02226952Phase 1/2
- Effects of Wood Smoke Particles on Influenza-induced Nasal Inflammation in Normal VolunteersCompletedNCT02183753Early Phase 1
- The Pilot Study of Chikungunya Virus Infections in Southern TaiwanCompletedNCT02174341
- Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis CTerminatedNCT02120274Phase 4
- Hepatitis C in Renal Transplant RecipientsStatus unknownNCT02108301Phase 4
- Intradermal Influenza Vaccine in the YoungCompletedNCT02103023Phase 3
- A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge ModelCompletedNCT02094365Phase 2
- Residual Sample Collection for Respiratory Viral PanelCompletedNCT02049918
- Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802TerminatedNCT02041715Phase 1
- Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults.CompletedNCT02022163Phase 1
- Probiotics in Prevention of Common ColdCompletedNCT02013934Not applicable
- Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXACompletedNCT02012998Phase 3
- Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .CompletedNCT02003703Phase 3
- Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in AdultsCompletedNCT01991587Phase 1/2
- Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.CompletedNCT01991561Phase 2
- Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSILCompletedNCT01957878Phase 2
- Genotypification and Predisposing Factors in Human Papilloma Virus InfectionCompletedNCT01924117Not applicable
- Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral InfectionsCompletedNCT01917461
- Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial)CompletedNCT01915394
- Preventing Bacterial and Viral Infections Among Injection Drug UsersCompletedNCT01892358Not applicable
- ATG in Haploidentical HSCT for Acute Graft-versus-host Disease ProphylaxisCompletedNCT01883180Phase 4
- Safety of H1N1 Influenza Vaccination in Pregnant WomenCompletedNCT01842997Phase 4
- Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster VaccinationCompletedNCT01839175Phase 3
- Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related AplasiaCompletedNCT01819792Phase 4
- Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in InfantsWithdrawnNCT01812135Phase 2
- Antimicrobial Stewardship for Primary Care PediatriciansCompletedNCT01806103Not applicable
- Optimizing Integrated PMTCT Services in Rural North-Central NigeriaCompletedNCT01805752Not applicable
- The Role of Viral Infection in Acute Exacerbations of Non-cystic Fibrosis Bronchiectasis in AdultsStatus unknownNCT01801657
- A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal CarcinomaCompletedNCT01800071Phase 1
- Clinic-based ART Diagnostic EvaluationCompletedNCT01791556Not applicable
- Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of AgeCompletedNCT01754428
- Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed ViolenceCompletedNCT01748968
- "Real-life" Cohort of Patients With Chronic Hepatitis B Virus InfectionStatus unknownNCT01732081
- Effect of 12-week Probiotic Supplementation on Bacterial and Viral Infections in Infants Aged 6 to 12 Months.CompletedNCT01724203Not applicable
- Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal DysfunctionCompletedNCT01708889Phase 1
- Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009CompletedNCT01706302
- Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of ValacyclovirCompletedNCT01689285Phase 1
- Palatability Testing of a New Paediatric Formulation of ValacyclovirCompletedNCT01682109Phase 4
- In Utero Treatment of Cytomegalovirus congénitale Infection With ValacyclovirCompletedNCT01651585Phase 4
- 300 Antibody Diagnostic Test KitStatus unknownNCT01646411
- Study of Subclinical Viral InfectionStatus unknownNCT01615341
- ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)CompletedNCT01600079
- Detecting Respiratory Viruses in Upper and Lower Respiratory Tract SamplesTerminatedNCT01597089